In today’s Times.
“Nice, the health watchdog, has ruled that 3.4 million adults are eligible for Mounjaro, the most effective so far in a revolutionary new class of anti-obesity injections. But a lack of NHS capacity means only 220,000 of these patients, fewer than one in ten, will be given the drug over the next three years, after spending years on waiting lists.
The arrival of weight-loss jabs has created a two-tier system for slimming down. Wealthy patients happy to pay £150 a month can easily get their hands on the miracle drugs, but anyone hoping to get them on the NHS may have to wait for years.
The drugs could ultimately “benefit a larger population”, because one in four adults in the UK — nearly 15 million people — are considered obese, meaning they have a BMI of more than 30.The rollout of Mounjaro will begin next year to patients who are already receiving care in specialist NHS weight-loss services”
The roll out is going to be incredibly slow and restricted due to capacity issues.